Orphan Versus Non-Orphan IPOs: The Difference Analyst Coverage Makes
نویسندگان
چکیده
منابع مشابه
No difference in between-country variability in use of newly approved orphan and non- orphan medicinal products - a pilot study
BACKGROUND Regulators and payers have to strike a balance between the needs of the patient and the optimal allocation of resources. Drugs indicated for rare diseases (orphan medicines) are a special group in this context because of their often high per unit costs. Our objective in this pilot study was to determine, for drugs used in an outpatient setting, how utilisation of centrally authorised...
متن کاملOrphan receptors.
Suppressor gene loci involved in the development of hepatocellular carcinoma (HCC) have not been fully identified. The aim of this study was to look for consistent allele loss, or loss of heterozygosity (LOH), in HCC which might represent such gene loci. We have prepared DNA from tumour and non-tumour material from 16 patients with HCC (nine with and seven without liver cirrhosis). Tumour DNA w...
متن کاملcomparison of early maladaptive schemas and cognitive emotion regulation orphan and non-orphan adolescents
0
متن کاملThe Aid Orphan Myth
The term ‘aid orphan’ refers to a developing country forgotten or abandoned by the development community. This metaphor has featured prominently in the development assistance policy and research literature over the past decade. Development practitioners, policy makers and researchers have defined aid orphans in manifold ways and often expressed concern over the potential fate or impact of such ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: SSRN Electronic Journal
سال: 2012
ISSN: 1556-5068
DOI: 10.2139/ssrn.2152864